Business Context and Reporting Period
This Form 10-Q covers Acxiom Corporation (not Liveramp Holdings, Inc., as indicated in the metadata) for the quarterly period ended December 31, 2001. Acxiom is a global leader in Customer Data Integration (CDI) and customer recognition infrastructure, providing software, database management services, and IT outsourcing. The filing reflects a period of significant restructuring, revenue recognition accounting changes, and economic headwinds.
Key Financial Metrics
| Metric | Q3 2001 | Q3 2000 | 9 Months 2001 | 9 Months 2000 |
|---|---|---|---|---|
| Revenue | $220.5 million | $262.7 million | $640.8 million | $766.2 million |
| Net Earnings (Loss) | $11.3 million | $23.7 million | $(45.3) million | $32.5 million |
| Operating Income (Loss) | $26.7 million | $44.3 million | $(46.1) million | $123.9 million |
| Cash from Operations (9mo) | $90.5 million (vs. $(14.3) million used in prior year) | |||
| Working Capital | $110.8 million (Dec 31, 2001) | |||
| Total Debt (Long-term + Current) | $447.7 million (Dec 31, 2001) | |||
| Cash and Equivalents | $1.3 million (Dec 31, 2001) |
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased 16% year-over-year for both the quarter and nine-month periods. Management attributes this to the economic slowdown and the impact of new revenue recognition policies (SAB 101) which shifted software license revenue from upfront to a subscription basis. On a pro forma basis adjusting for accounting changes, revenue declined 10% for the quarter and 9% for the nine months.
- Restructuring Charges: The company recorded aggregate restructuring charges of $45.3 million in the first half of the fiscal year, including a $31.2 million loss on a sale-leaseback of computer equipment, $8.3 million in severance, and $25.8 million in accelerated depreciation/amortization. These charges drove the nine-month operating loss.
- Segment Performance:
- Services: Down 19% (8% pro forma) due to reduced incremental project work.
- Data and Software Products: Down 22% (up 11% pro forma) driven by increased data license sales.
- IT Management: Down 7% (flat pro forma excluding the terminated Montgomery Ward contract).
- Divestitures: The company sold three business operations (SIGMA, Buckley Dement, and minor U.K. units) for $15.1 million, recording a net gain of $1.1 million.
Guidance, Outlook, and Risks
- Capital Markets Activity: On February 6, 2002, Acxiom completed a $160 million offering of 3.75% convertible subordinated notes due 2009. Proceeds will be used to redeem $115 million of existing convertible notes due in 2003, repay $25.7 million of senior notes, and reduce revolver borrowings.
- Liquidity: Despite a low cash balance of $1.3 million, the company maintains $175 million in available credit under its revolving facility (reduced from $265 million). Management expects existing debt capacity and operating cash flow to meet requirements.
- Accounting Changes: The company adopted SFAS No. 142, discontinuing goodwill amortization effective April 1, 2001. This is expected to increase net income by approximately $7 million for the fiscal year ending March 31, 2002.
- Risks and Contingencies:
- Customer Concentration: Allstate Insurance accounted for 10.3% of nine-month revenue ($65.8 million).
- Joint Ventures: The company has advanced $4.8 million to fund losses in two joint ventures. If these do not become profitable, an impairment charge up to $10.9 million may be required.
- Legal: A shareholder class action regarding a 1999 stock offering was dismissed but is under appeal.
- Investment Impairments: Recorded $1.0 million in "other than temporary" investment losses and $0.9 million in temporary impairments during the quarter.
Investor Verification Checklist
- Verify the impact of the new $160 million convertible note issuance on future interest expenses and potential equity dilution (conversion price $18.25).
- Confirm the sustainability of operating cash flows given the low cash balance ($1.3M) and reliance on the revolving credit facility.
- Monitor the status of the two joint ventures requiring funding; assess the risk of a potential $10.9 million impairment charge.
- Review the pro forma revenue adjustments to understand the true organic growth rate versus accounting policy shifts (SAB 101).
- Assess the timeline for the reinstatement of voluntary and involuntary salary reductions (scheduled for fiscal 2003), which could increase operating expenses by ~$16 million.